|Page (1) of 1 - 12/07/17||email article||print page|
(December 07, 2017)
The Worldwide Unnatural Amino Acids Market Increasing demand for unnatural amino acids for the development of finished pharmaceutical products, increasing research and development activities in pharmaceuticals and manufacturing of active pharmaceutical industry drive the growth of the market.
Unnatural amino acids are a chemically synthesized or naturally occurring non-proteinogenic amino acids. A large number of amino acid derivatives are used as building blocks or primary ingredients for a number of pharmaceutical compounds, which act as molecular scaffolds in various pharmaceutical products. They are molecular scaffolds or pharmacologically active products and have diverse structural elements that lead to the development of new peptide and non-peptide compounds having a number of applications in the chemical industry as well as pharmaceuticals industry.
Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/4909 .
The Global Unnatural Amino Acids Market is segmented on the basis of types, indication, and end users.
On the basis of THE types, the market is segmented into non-alpha, D-Amino Acids, L-Amino Acid, and others. The non-alpha type is further segmented into ▀-amino acids, ▀-amino acid derivatives, ?-aminobutyric acid, and others. D-Amino Acids is further segmented into D-alanine, D-glutamate, and others.
On the basis of the indication, the market is segmented into liver diseases, cancer, genetic diseases, inflammatory disease, and others.
On the basis of the end users, the market is segmented into pharmaceutical & biotechnological companies, hospital & clinics, academic institutes, and others.
Some of key the players in the market are Merck KGaA (Germany), CordenPharma International (Germany), YONEYAMA YAKUHIN KOGYO CO.,LTD.á (Japan), Sekisui XenoTech, LLC. (U.S.) , Varsal (U.S.), Biosyn (U.S.), NAGASE & CO., LTD. (Japan), Kyowa Hakko Europe GmbH, AbbVie, Inc. (U.S.), Ajinomoto Co., Inc. (Japan), AminoLogics Co. Ltd. (South Korea), AnaSpec, Inc. (U.S.), BASF SE (Germany), Biological E Ltd. (India), C-TRI Co., Ltd. (South Korea), and Evonik Industries AG (Germany), Divis Laboratories Ltd. (India), Donboo Amino Acid Co., Ltd. (China), DSM Sinochem Pharmaceuticals (Singapore), EMD Millipore (USA), Enzo Life Sciences, Inc. (USA), Evonik Industries AG (Germany), GlaxoSmithKline plc (U.K), Novartis AG (Switzerland), Pfizer, Inc. (the USA), Ranbaxy Laboratories Ltd. (India), and Sanofi (France).
Major TOC for Unnatural Amino Acids Market:
- 1. Report Prologue
Related Keywords:Business,Health & Medicine,Science,U.S,World,
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , IBN - IT Weekly Newsletter , DMN Newswire Newsletter
Source:Copyright (c) AB Digital, Inc. All Rights Reserved